Severe ADAMTS13 Deficiency in Adult Idiopathic Thrombotic Microangiopathies Defines a Subset of Patients Characterized by Various Autoimmune Manifestations, Lower Platelet Count, and Mild Renal Involvement-Reference-Cited by-同舟云学术

Severe ADAMTS13 Deficiency in Adult Idiopathic Thrombotic Microangiopathies Defines a Subset of Patients Characterized by Various Autoimmune Manifestations, Lower Platelet Count, and Mild Renal Involvement

Published:2004-07 Issue:4 Volume:83 Page:233-244
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Coppo Paul,Bengoufa Djaouida,Veyradier Agnès,Wolf Martine,Bussel Annette,Millot Gaël Armel,Malot Sandrine,Heshmati Farhad,Mira Jean-Paul,Boulanger Emmanuelle,Galicier Lionel,Durey-Dragon Marie-Agnès,Frémeaux-Bacchi Véronique,Ramakers Michel,Pruna André,Bordessoule Dominique,Gouilleux Valérie,Scrobohaci Marie-Lorraine,Vernant Jean-Paul,Moreau Delphine,Azoulay Elie,Schlemmer Benoît,Guillevin Loïc,Lassoued Kaïss

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference60 articles.

1. First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange.;Baron;J Clin Apheresis,2002

2. Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: The concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange.;Baron;J Clin Apheresis,2001

3. Thrombotic thrombocytopenic purpura in systemic sclerosis.;Barton;J Rheumatol,1989

4. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: A severely deficient activity is specific for thrombotic thrombocytopenic purpura.;Bianchi;Blood,2002

5. Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. Evolving concepts of pathogenesis and therapy.;Byrnes;Clin Haematol,1986

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identify the influences of systemic lupus erythematosus on acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura using comprehensive bioinformatics analysis;Lupus;2023-10-17

2. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023;International Journal of Hematology;2023-09-10

3. Thrombotic thrombocytopenic purpura that developed 3 years after systemic lupus erythematosus had remitted with rituximab therapy;Modern Rheumatology Case Reports;2023-06-10

4. Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea;Annals of Laboratory Medicine;2023-04-21

5. Severe Thrombotic Thrombocytopenic Purpura (TTP) with Organ Failure in Critically Ill Patients;Journal of Clinical Medicine;2022-02-19